The Niemann Pick C Disease market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Niemann Pick C Disease: An Overview
Niemann–Pick disease type C (NPC) is a rare progressive genetic disorder characterized by an inability of the body to transport cholesterol and other fatty substances (lipids) inside the cells. This inability leads to the abnormal accumulation of these substances within various tissues of the body and brain tissue.
In the severe form of the disease, the patient can present early with failure to thrive, hepatosplenomegaly, or pulmonary manifestations. The diagnosis of NPC is based on characteristic symptoms like psychiatric issues, neurologic findings, etc. Sometimes this disorder is misdiagnosed for other associated neurological disorders.
Niemann Pick C Disease Market Key Facts
According to DelveInsight analysis, the total prevalent population of Niemann–Pick disease type C (NPC) in the 7MM was observed to be 2,100+ in 2017.
The analysis suggests the highest prevalence of NPC in the US with 1,000+ cases in 2017.
Among the 7MM, the most prevalent cases of Niemann Pick C disease were recorded in the United States.
Among the European 5 countries, Germany had the highest prevalent population of NPC. On the other hand, Spain had the lowest prevalent population of NPC.
Among the 7MM, the US accounts for the 32% market share of the overall market size of NPC in 2017, while Japan accounts for the 10% market share of the overall market in 2017.
According to DelveInsight, the therapeutic market of Niemann–Pick Type C (NPC) in the seven major markets was assessed to be USD 28.676 million in 2017 which is expected to grow during the study period.
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Niemann Pick C Disease market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives complete detail of the Niemann Pick C Disease market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.
Niemann Pick C Disease Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.
Niemann Pick C Disease Epidemiology Segmentation
Total prevalence of Niemann-Pick disease type C (NPC)
Subtype-specific Prevalence of Niemann-Pick disease type C (NPC)
Diagnosed Prevalent Population of Niemann-Pick disease type C (NPC)
Prevalence of Diagnosed Cases of Niemann-Pick disease type C (NPC) based on Clinical Phenotypes
Niemann Pick C Disease Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Niemann Pick C Disease market or expected to get launched during the study period. The analysis covers Niemann Pick C Disease market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Niemann Pick C Disease Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Request for Sample PDF Report – https://www.delveinsight.com/sample-request/niemann-pick-c-disease-market
Niemann Pick C Disease Therapeutics Analysis
In contrast to the US therapeutic market, the current therapeutic market size of NPC in the EU-5 countries and Japan is dominated by the use of only approved drug Zavesca/Brazaves [Miglustat; Actelion] and the supportive therapies.
The Niemann-Pick disease type C (NPC) market dynamics is anticipated to change in the coming years owing to the rise in healthcare spending across the world. Several key players are involved in developing drugs for Niemann-Pick disease type C (NPC), which are expected to launch in the coming years.
Some of the key companies in the Niemann Pick C Disease market include:
Niemann Pick C Disease Therapies covered in the report include:
Trappsol Cyclo (hydroxypropyl-beta-cyclodextrins)
And many more.
The available therapeutics treatment options in Niemann Pick C Disease Landscape aim to reduce complications linked with the disease.
Get More Detailed Insights Into the Emerging Therapies & Key Companies – https://www.delveinsight.com/sample-request/niemann-pick-c-disease-market
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Niemann Pick C Disease Competitive Intelligence Analysis
4. Niemann Pick C Disease Market Overview at a Glance
5. Niemann Pick C Disease Disease Background and Overview
6. Niemann Pick C Disease Patient Journey
7. Niemann Pick C Disease Epidemiology and Patient Population
8. Niemann Pick C Disease Treatment Algorithm, Current Treatment, and Medical Practices
9. Niemann Pick C Disease Unmet Needs
10. Key Endpoints of Niemann Pick C Disease Treatment
11. Niemann Pick C Disease Marketed Products
12. Niemann Pick C Disease Emerging Therapies
13. Niemann Pick C Disease Seven Major Market Analysis
14. Attribute Analysis
15. Niemann Pick C Disease Market Outlook (7 major markets)
16. Niemann Pick C Disease Access and Reimbursement Overview
17. KOL Views on the Niemann Pick C Disease Market.
18. Niemann Pick C Disease Market Drivers
19. Niemann Pick C Disease Market Barriers
21. DelveInsight Capabilities
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF Report – https://www.delveinsight.com/sample-request/niemann-pick-c-disease-market
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Other Trending Healthcare Reports by DelveInsight
“Dense Deposit Disease Market” report delivers an in-depth understanding of the Dense Deposit Disease, historical and forecasted epidemiology as well as the Dense Deposit Disease market trends in 7MM.
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States